• Home
  • Company Info
    • General Information
    • Nature of Business
    • Business Structure
    • Company Milestone
    • Message from Chairman
    • Organization Chart
    • Board of Directors
    • Sub-Committees
      • Audit Committee
      • Nomination and Remuneration Committee
      • Corporate Governance and Sustainable Development Committee
      • Risk Management Committee
    • Management Team
  • Financial Info
    • Financial Highlights
    • Financial Statements
    • Management Discussion and Analysis
  • Stock Info
    • Stock Quotes
    • Historical Price
    • Investment Calculator
  • Shareholder Info
    • Major Shareholders
    • Dividend Policy and Payment
    • Shareholders' Meeting
    • IR Calendar
    • Newly Issued Ordinary Shares
    • Warrant Information
  • Corporate Governance
    • Corporate Governance Policy
    • Charters
    • Whistleblowing Channel Form
  • Publications
    • Investor Kits
    • Prospectus
    • Annual Report / Form 56-1
    • CSR Gallery
    • Presentations and Webcast
  • Newsroom
    • SET Announcements
    • Press Releases
    • News Clippings
    • Videos
    • Analyst Research
    • Online News
    • Company Announcement
  • Information Inquiry
    • IR Contact
    • Email Alerts
  1. Home
  2. Newsroom
  3. SET Announcements

SET Announcements

Board Resolutiin Re: The Acquisition ordinary shares of Interpharma- ZEAvita Co., Ltd. (Associate company) (Revised)

12 November 2025
Read More

Board Resolutiin Re: The Acquisition ordinary shares of Interpharma- ZEAvita Co., Ltd. (Associate company)

12 November 2025
Read More

Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025

11 November 2025
Read More

Financial Performance Quarter 3 (F45) (Reviewed)

11 November 2025
Read More

Financial Statement Quarter 3/2025 (Reviewed)

11 November 2025
Read More

Invitation for Shareholders to propose Agenda in advance for the 2026 Annual General Meeting, Candidates in the Election of the Company's Directors

30 September 2025
Read More

Notification of the Company's holiday for the year 2026

30 September 2025
Read More

Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025

14 August 2025
Read More

Financial Performance Quarter 2 (F45) (Reviewed)

14 August 2025
Read More

Financial Statement Quarter 2/2025 (Reviewed)

14 August 2025
Read More

Report on the Utilization of Capital Increased from the exercise IP-W2

25 July 2025
Read More

New shares of IP to be traded on June 27, 2025

26 June 2025
Read More
  • ‹
  • 1
  • 2
  • 3
  • ›

Follow Us

  • Home
  • Company Info
    • General Information
    • Nature of Business
    • Business Structure
    • Company Milestone
    • Message from Chairman
    • Organization Chart
    • Board of Directors
    • Sub-Committees
    • Management Team
  • Financial Info
    • Financial Highlights
    • Financial Statements
    • Management Discussion and Analysis
  • Stock Info
    • Stock Quotes
    • Historical Price
    • Investment Calculator
  • Shareholder Info
    • Major Shareholders
    • Dividend Policy and Payment
    • Shareholders' Meeting
    • IR Calendar
    • Newly Issued Ordinary Shares
    • Warrant Information
  • Corporate Governance
    • Corporate Governance Policy
    • Charters
    • Whistleblowing Channel Form
  • Publications
    • Investor Kits
    • Prospectus
    • Annual Report / Form 56-1
    • CSR Gallery
    • Presentations and Webcast
  • Newsroom
    • SET Announcements
    • Press Releases
    • News Clippings
    • Videos
    • Analyst Research
    • Online News
    • Company Announcement
  • Information Inquiry
    • IR Contact
    • Email Alerts

© Copyright - Interpharma Group

  • Sitemap
  • Terms and Conditions